# Executive summary

Дата среза: 2026-07-29. Классификация: evidence-backed technical audit, не
clinical validation и не юридическое заключение.

## Verdict

- Technical production readiness: **NO-GO**.
- Clinical readiness: **NO-GO**.
- Local/mock research prototype: **CONDITIONAL GO**.
- Quality Score: **36.3/100**, с override failed safety gates.

## STOP-SHIP

1. Утверждённый лицензированный immutable model artifact отсутствует.
2. End-to-end real inference не воспроизведён.
3. Независимая patient-level external validation отсутствует.
4. Biological QC/OOD/reject отсутствует.
5. Cell score нельзя преобразовывать в patient diagnosis.

## Top-5 risks

| Risk | Severity | Evidence |
|---|---|---|
| Нет external patient validation | Critical | G2 FAIL |
| Опасный false negative при misuse | Critical | QC/OOD и clinical controls отсутствуют |
| Cell result принят за patient diagnosis | High/STOP-SHIP | нет aggregation/clinical workflow |
| Mutable/unverified model chain | High/STOP-SHIP | artifact manifest отсутствует |
| Anonymous resource exhaustion | High | нет auth/global quota |

## Top-5 recommendations

1. Утвердить model/license/revision/checksum/labels/preprocessing.
2. Утвердить intended purpose и claim boundary.
3. Выполнить clean/offline real-model smoke.
4. Создать leakage-safe patient/slide/cell registry и external validation.
5. Реализовать QC/OOD/selective reject с human review.

## VERIFIED

- API/UI research-only contract, upload safeguards и bounded inference.
- Privacy-safe JSON logs, no-store/version/request headers.
- 78 tests, 88.52% branch coverage, Ruff, strict mypy, `pip check`.
- Python 3.11/3.12 GitHub Actions success на `fc47dac`.
- T0/T1 synthetic benchmark и offline math/robustness planning utilities.

## UNKNOWN / NOT EXECUTED

- Реальная accuracy/Se/Sp/AUROC/calibration модели.
- Labels, preprocessing, license и size отсутствующего artifact.
- Data leakage и subgroup performance.
- T2/T3 model/container capacity, Docker build/CVE scan.
- External-site robustness, prospective workflow и regulatory classification.

Полные findings: `phase19/CONSOLIDATED_FINDINGS.csv`. Рекомендации:
`phase19/PRIORITIZED_RECOMMENDATIONS.csv`.
